News

Mauna Kea Technologies Announces its 2025 Financial Calendar

14 January 2025

Paris and Boston, January 14, 2025 – 5:45 p.m. CET – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE)
platform, today announces the publication of its 2025 Financial Calendar.

EventsDates*
Fourth Quarter 2024 SalesJanuary 15, 2025
Full-Year 2024 Financial ResultsApril 24, 2025
Annual General MeetingJune 5, 2025
Half-Year 2025 Financial ResultsOctober 2, 2025

*Subject to modification. Press releases are published after market closes.

READ THE FULL PRESS RELEASE

Latest News

Mauna Kea Technologies Announces Largest Annual Pancreatic Cyst Consortium at Digestive Disease Week® 2025 

Mauna Kea Technologies Announces Largest Annual Pancreatic Cyst Consortium at Digestive Disease Week® 2025 

Publication of the 2024 Annual Financial Report 

Publication of the 2024 Annual Financial Report 

Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week® 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio® in Key Indications 

Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week® 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio® in Key Indications 

No results found.